Report Detail

Pharma & Healthcare Global Imatinib Drugs Market Professional Survey Report 2019

  • RnM2775715
  • |
  • 17 January, 2019
  • |
  • Global
  • |
  • 104 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Imatinib Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Imatinib Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Imatinib Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Imatinib Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Imatinib Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Apotex Inc.
Novartis
Sanofi S.A.
Cipla Inc.
Mylan Pharms Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Capsules
Tablets

Segment by Application
Hospitals
Drug Stores
Other


Table of Contents

    Executive Summary

      1 Industry Overview of Imatinib Drugs

      • 1.1 Definition of Imatinib Drugs
      • 1.2 Imatinib Drugs Segment by Type
        • 1.2.1 Global Imatinib Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Capsules
        • 1.2.3 Tablets
      • 1.3 Imatinib Drugs Segment by Applications
        • 1.3.1 Global Imatinib Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Drug Stores
        • 1.3.4 Other
      • 1.4 Global Imatinib Drugs Overall Market
        • 1.4.1 Global Imatinib Drugs Revenue (2014-2025)
        • 1.4.2 Global Imatinib Drugs Production (2014-2025)
        • 1.4.3 North America Imatinib Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Imatinib Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Imatinib Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Imatinib Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Imatinib Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Imatinib Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Imatinib Drugs
      • 2.3 Manufacturing Process Analysis of Imatinib Drugs
      • 2.4 Industry Chain Structure of Imatinib Drugs

      3 Development and Manufacturing Plants Analysis of Imatinib Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Imatinib Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Imatinib Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Imatinib Drugs Production and Capacity Analysis
      • 4.2 Imatinib Drugs Revenue Analysis
      • 4.3 Imatinib Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Imatinib Drugs Regional Market Analysis

      • 5.1 Imatinib Drugs Production by Regions
        • 5.1.1 Global Imatinib Drugs Production by Regions
        • 5.1.2 Global Imatinib Drugs Revenue by Regions
      • 5.2 Imatinib Drugs Consumption by Regions
      • 5.3 North America Imatinib Drugs Market Analysis
        • 5.3.1 North America Imatinib Drugs Production
        • 5.3.2 North America Imatinib Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Imatinib Drugs Import and Export
      • 5.4 Europe Imatinib Drugs Market Analysis
        • 5.4.1 Europe Imatinib Drugs Production
        • 5.4.2 Europe Imatinib Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Imatinib Drugs Import and Export
      • 5.5 China Imatinib Drugs Market Analysis
        • 5.5.1 China Imatinib Drugs Production
        • 5.5.2 China Imatinib Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Imatinib Drugs Import and Export
      • 5.6 Japan Imatinib Drugs Market Analysis
        • 5.6.1 Japan Imatinib Drugs Production
        • 5.6.2 Japan Imatinib Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Imatinib Drugs Import and Export
      • 5.7 Southeast Asia Imatinib Drugs Market Analysis
        • 5.7.1 Southeast Asia Imatinib Drugs Production
        • 5.7.2 Southeast Asia Imatinib Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Imatinib Drugs Import and Export
      • 5.8 India Imatinib Drugs Market Analysis
        • 5.8.1 India Imatinib Drugs Production
        • 5.8.2 India Imatinib Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Imatinib Drugs Import and Export

      6 Imatinib Drugs Segment Market Analysis (by Type)

      • 6.1 Global Imatinib Drugs Production by Type
      • 6.2 Global Imatinib Drugs Revenue by Type
      • 6.3 Imatinib Drugs Price by Type

      7 Imatinib Drugs Segment Market Analysis (by Application)

      • 7.1 Global Imatinib Drugs Consumption by Application
      • 7.2 Global Imatinib Drugs Consumption Market Share by Application (2014-2019)

      8 Imatinib Drugs Major Manufacturers Analysis

      • 8.1 Apotex Inc.
        • 8.1.1 Apotex Inc. Imatinib Drugs Production Sites and Area Served
        • 8.1.2 Apotex Inc. Product Introduction, Application and Specification
        • 8.1.3 Apotex Inc. Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis Imatinib Drugs Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sanofi S.A.
        • 8.3.1 Sanofi S.A. Imatinib Drugs Production Sites and Area Served
        • 8.3.2 Sanofi S.A. Product Introduction, Application and Specification
        • 8.3.3 Sanofi S.A. Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Cipla Inc.
        • 8.4.1 Cipla Inc. Imatinib Drugs Production Sites and Area Served
        • 8.4.2 Cipla Inc. Product Introduction, Application and Specification
        • 8.4.3 Cipla Inc. Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Mylan Pharms Inc.
        • 8.5.1 Mylan Pharms Inc. Imatinib Drugs Production Sites and Area Served
        • 8.5.2 Mylan Pharms Inc. Product Introduction, Application and Specification
        • 8.5.3 Mylan Pharms Inc. Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Glenmark Pharmaceuticals Ltd.
        • 8.6.1 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Production Sites and Area Served
        • 8.6.2 Glenmark Pharmaceuticals Ltd. Product Introduction, Application and Specification
        • 8.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sun Pharmaceuticals
        • 8.7.1 Sun Pharmaceuticals Imatinib Drugs Production Sites and Area Served
        • 8.7.2 Sun Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 Sun Pharmaceuticals Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Actavis Generics
        • 8.8.1 Actavis Generics Imatinib Drugs Production Sites and Area Served
        • 8.8.2 Actavis Generics Product Introduction, Application and Specification
        • 8.8.3 Actavis Generics Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Dr. Reddy's Laboratories
        • 8.9.1 Dr. Reddy's Laboratories Imatinib Drugs Production Sites and Area Served
        • 8.9.2 Dr. Reddy's Laboratories Product Introduction, Application and Specification
        • 8.9.3 Dr. Reddy's Laboratories Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Teva Pharmaceutical Industries Ltd.
        • 8.10.1 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Production Sites and Area Served
        • 8.10.2 Teva Pharmaceutical Industries Ltd. Product Introduction, Application and Specification
        • 8.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Imatinib Drugs Market

      • 9.1 Global Imatinib Drugs Market Trend Analysis
        • 9.1.1 Global Imatinib Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Imatinib Drugs Regional Market Trend
        • 9.2.1 North America Imatinib Drugs Forecast 2019-2025
        • 9.2.2 Europe Imatinib Drugs Forecast 2019-2025
        • 9.2.3 China Imatinib Drugs Forecast 2019-2025
        • 9.2.4 Japan Imatinib Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Imatinib Drugs Forecast 2019-2025
        • 9.2.6 India Imatinib Drugs Forecast 2019-2025
      • 9.3 Imatinib Drugs Market Trend (Product Type)
      • 9.4 Imatinib Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Imatinib Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Imatinib Drugs . Industry analysis & Market Report on Imatinib Drugs is a syndicated market report, published as Global Imatinib Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Imatinib Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,796.50
        4,194.75
        5,593.00
        3,265.50
        4,898.25
        6,531.00
        544,425.00
        816,637.50
        1,088,850.00
        291,655.00
        437,482.50
        583,310.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report